Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Operating Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Operating Income for 17 consecutive years, with $3.8 million as the latest value for Q1 2026.

  • Quarterly Operating Income fell 53.48% to $3.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $37.4 million through Jan 2026, down 43.56% year-over-year, with the annual reading at $37.4 million for FY2026, 43.56% down from the prior year.
  • Operating Income for Q1 2026 was $3.8 million at Usana Health Sciences, up from $1.2 million in the prior quarter.
  • The five-year high for Operating Income was $46.2 million in Q1 2022, with the low at $1.2 million in Q3 2025.
  • Average Operating Income over 5 years is $20.6 million, with a median of $22.6 million recorded in 2022.
  • The sharpest move saw Operating Income rose 7.4% in 2023, then tumbled 92.15% in 2025.
  • Over 5 years, Operating Income stood at $22.6 million in 2022, then grew by 7.4% to $24.2 million in 2023, then plummeted by 66.1% to $8.2 million in 2024, then tumbled by 85.09% to $1.2 million in 2025, then skyrocketed by 212.01% to $3.8 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods came in at $3.8 million, $1.2 million, and $16.7 million for Q1 2026, Q3 2025, and Q2 2025 respectively.